Company Profile
Updated: 17-SEP-09Celsion Corp.
Exporter
10220-L Old Columbia Rd., Ste. I, Columbia, MD 21046-1716, United States
(410)290-5390, (410)290-5394 fax, http://www.celsion.com
Primary SIC: Electromedical Apparatus, Primary NAICS: Electromedical and Electrotherapeutic Apparatus Manufacturing
Description: Manufacturing: Medical equipment
View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!
Celsion Posts 3Q 2009 Financial Results and Business Update.(Financial report)
Health & Beauty Close-Up; 11/13/2009; 1280 words; Celsion Corp., an oncology drug development company...the commercialization of ThermoDox, Celsion's heat activated liposomal encapsulation...ThermoDox is a registered trademark of Celsion Corp. ((Comments on this story may be sent...
Other News To Note.
BIOWORLD Today; 11/4/2009; 2590 words; ...polyglutamate polymer. Celsion Corp., of Columbia, Md...evaluation to determine whether Celsion's doxorubicin-laden...will improve therapy. Celsion's drug delivery technology...Switzerland, and Dyax Corp., of Cambridge, Mass...
Appointments And Advancements.
BIOWORLD Today; 11/3/2009; 1153 words; ...Alteon Inc., its chairman. BioVeris Corp., of Gaithersburg, Md., appointed...Banck and Edwin Meese to its board. Celsion Corp., of Columbia, Md., appointed...president of product development. Genzyme Corp., of Cambridge, Mass., elected...
Clinic Roundup.
BIOWORLD Today; 11/3/2009; 1336 words; ...renal disease. About 198 patients will be enrolled, paralleling a pivotal U.S. trial that's already under way. o Celsion Corp., of Columbia, Md., said a Phase I dose-escalation study of ThermoDox for nonresectable liver cancer has completed...
Short Sale Recap. Highest % Of Daily Trading Volume Short All Exchanges Combined For Wednesday.
M2 Presswire; 10/15/2009; 3352 words; ...CBRL), GlobalStar (NASDAQ: GSAT), Optimer Pharmaceuticals (NASDAQ: OPTR), Vistaprint (NASDAQ: VPRT) and Celsion Corp (NASDAQ: CLSN). To access SqueezeTrigger Prices ahead of potential short squeezes beginning, visit http://www...
Recent News Articles
- Celsion Corporation Announces $7.1 Million Registered Direct Offering.
Business Wire - September 28, 2009 - Video: Celsion Corporation Initiates Enrollment Awareness Program for Pivotal Phase I/II DIGNITY Trial of ThermoDox(R) in Patients with Recurrent Chest Wall (RCW) Breast Cancer.
PR Newswire - September 28, 2009 - Michael H. Tardugno of Celsion Corp(NasdaqGM: CLSN) bought Shares of CLSN.
M2 Presswire - August 18, 2009 - Celsion Corp - Therapeutic Competitors.
M2 Presswire - June 22, 2009
Why Purchase This Company Profile?
- Sales prospecting
- Competitive analysis
- Vendor & supplier evaluation
- Customer evaluation and analysis
- Strategic planning